London-listed private equity investor F&C Private Equity has held a EUR 30m first close of its Aurora Fund, a new vehicle focused on acquiring secondary interests in predominately European private equity funds and co-investments.
Also backing the biotech startup were the Zürcher Kantonalbank and Greencross Medical Science Corp
Company plans to use the fresh capital to further expand, develop new features and scale up its team
EVentures, 468 Capital and HV Holtzbrinck back the round for the climate change mitigation app
Clessidra has been in negotiations for the acquisition of the Italian wine producer since February 2020